# Evaluation of a New Sequencing Strategy in Autoinflammatory Siseases (BIOSAID)

> **NCT02976948** · — · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 299 (actual)

## Conditions studied

- Systemic Autoinflammatory Diseases (SAID)

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02976948
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-31
- **Primary completion:** 2019-07-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 299 (ACTUAL)
- **Why stopped:** Inclusion of the last patient
- **Last updated:** 2021-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976948, "Evaluation of a New Sequencing Strategy in Autoinflammatory Siseases (BIOSAID)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02976948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*